Innovaderm Research has been picked by Welichem Biotech to run the Phase I clinical trial of the firm’s anti-psoriasis drug candidate.Under the terms of the deal, where financial details were not disclosed, Innovaderm is responsible for the strict protocols, data gathering, and patient monitoring necessary to comply with applicable standards and procedures.
